Grasim Industries confirms ₹3,999.80 crore rights issue funds utilization

Grasim Industries Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report, issued by CARE Ratings Limited, confirms that the proceeds from the company’s ₹3,999.80 crore Rights Issue have been utilized appropriately and in line with the objects disclosed in the offer document. There have been no material deviations or variations in the fund utilization during the reported quarter.

Monitoring Agency Report Highlights Fund Utilization

Grasim Industries Limited has officially communicated the findings of its Monitoring Agency Report for the quarter that concluded on September 30, 2026. The report, prepared by CARE Ratings Limited, serves to provide an objective overview of how the proceeds from the company’s Rights Issue have been managed. The total value of the Rights Issue was aggregated at ₹3,999.80 crore.

Confirmation of Proper Fund Usage

A key finding from the report is the confirmation that the utilization of funds raised through the Rights Issue aligns with the objectives previously stated in the company’s offer document. CARE Ratings Limited has verified that the funds have been deployed appropriately. The report explicitly states that there has been no variation or deviation observed in the utilization of these funds during the specified quarter.

Transparency and Accessibility

Further enhancing transparency, Grasim Industries Limited has also made this information available on its official website, www.grasim.com. This ensures that stakeholders, including investors and the public, can easily access and review the details of the fund utilization. The company’s commitment to timely reporting and adherence to regulatory requirements underscores its focus on maintaining investor confidence.

Key Financial Details

The Rights Issue, which took place from January 17, 2024, to January 29, 2024, had an offer price of ₹1,812 per share. The total issue size was ₹3,999.80 crore. The report indicates that a significant portion of the proceeds, specifically ₹3,971.81 crore, had been utilized by the end of the quarter, with a remaining unutilized balance of ₹1.04 crore after accounting for issue expenses. The primary objects of the issue included repayment or prepayment of borrowings (₹3,000.00 crore) and general corporate purposes (₹977.65 crore). The utilization for general corporate purposes was primarily towards employee expenses.

Source: BSE

Previous Article

Edelweiss reports 50% YoY PAT growth for Q2 FY27